Medpace Holdings SG&A Expenses 2014-2024 | MEDP

Medpace Holdings sg&a expenses for the twelve months ending June 30, 2024 were $0.169B, a 15.87% increase year-over-year.

  • Medpace Holdings annual sg&a expenses for 2023 were $0.161B, a 22.79% increase from 2022.
  • Medpace Holdings annual sg&a expenses for 2022 were $0.131B, a 21.19% increase from 2021.
  • Medpace Holdings annual sg&a expenses for 2021 were $0.108B, a 17.65% increase from 2020.

Medpace Holdings SG&A Expenses 2014-2024 | MEDP

  • Medpace Holdings annual sg&a expenses for 2023 were $0.161B, a 22.79% increase from 2022.
  • Medpace Holdings annual sg&a expenses for 2022 were $0.131B, a 21.19% increase from 2021.
  • Medpace Holdings annual sg&a expenses for 2021 were $0.108B, a 17.65% increase from 2020.